Lupin Debuts on TIME-Statista Sustainable Companies List at No. 318
Event summary
- Lupin ranked 318th among 750 companies in TIME-Statista's 2026 sustainability ranking, one of 16 Indian firms included.
- Assessment covered 20+ indicators including ESG commitments, reporting transparency, and environmental/social performance.
- Builds on Lupin's CDP 'A' ratings for Climate Change and Water Security, plus S&P Global Sustainability Assessment score of 91 in 2025.
The big picture
Lupin's inclusion in this prestigious sustainability ranking signals growing investor and regulatory focus on ESG performance within the pharmaceutical sector. As one of only 16 Indian companies recognized, this positions Lupin as a potential regional leader in sustainable healthcare practices. The recognition comes amid increasing global scrutiny of pharmaceutical supply chains and manufacturing processes.
What we're watching
- Sustainability Execution
- Whether Lupin can maintain its ESG momentum amid global pharmaceutical industry pressures.
- Regulatory Alignment
- How evolving sustainability reporting standards may impact Lupin's future rankings.
- Competitive Positioning
- The pace at which other Indian pharma companies adopt similar ESG strategies.
Related topics